{"nct_id":"NCT02054806","title":"Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)","status":"COMPLETED","status_verified_date":"2023-02","start_date":"2014-02-17","start_date_type":"ACTUAL","primary_completion_date":"2021-04-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}